SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral spike vaccines

被引:150
|
作者
Shen, Xiaoying [1 ,2 ]
Tang, Haili [1 ]
McDanal, Charlene [1 ]
Wagh, Kshitij [3 ]
Fischer, William [3 ]
Theiler, James [3 ]
Yoon, Hyejin [3 ]
Li, Dapeng [2 ]
Haynes, Barton F. [2 ,6 ]
Sanders, Kevin O. [1 ,2 ]
Gnanakaran, Sandrasegaram [3 ]
Hengartner, Nick [3 ]
Pajon, Rolando [4 ]
Smith, Gale [5 ]
Glenn, Gregory M. [5 ]
Korber, Bette [3 ]
Montefiori, David C. [1 ,2 ]
机构
[1] Duke Univ, Dept Surg, Sch Med, Durham, NC 27708 USA
[2] Duke Univ, Duke Human Vaccine Inst, Sch Med, Durham, NC 27708 USA
[3] Los Alamos Natl Lab, Theoret Biol & Biophys, Los Alamos, NM USA
[4] Moderna Inc, Cambridge, MA USA
[5] Novavax Inc, Gaithersburg, MD USA
[6] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA
基金
美国国家卫生研究院;
关键词
VIVO;
D O I
10.1016/j.chom.2021.03.002
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
All current vaccines for COVID-19 utilize ancestral SARS-CoV-2 spike with the goal of generating protective neutralizing antibodies. The recent emergence and rapid spread of several SARS-CoV-2 variants carrying multiple spike mutations raise concerns about possible immune escape. One variant, first identified in the United Kingdom (B.1.1.7, also called 20I/501Y.V1), contains eight spike mutations with potential to impact antibody therapy, vaccine efficacy, and risk of reinfection. Here, we show that B.1.1.7 remains sensitive to neutralization, albeit at moderately reduced levels (similar to sim;2-fold), by serum samples from convalescent individuals and recipients of an mRNA vaccine (mRNA-1273, Moderna) and a protein nanoparticle vaccine (NVX-CoV2373, Novavax). A subset of monoclonal antibodies to the receptor binding domain (RBD) of spike are less effective against the variant, while others are largely unaffected. These findings indicate that variant B.1.1.7 is unlikely to be a major concern for current vaccines or for an increased risk of reinfection.
引用
收藏
页码:529 / +
页数:14
相关论文
共 50 条
  • [21] Introduction and transmission of SARS-CoV-2 lineage B.1.1.7, Alpha variant, in Denmark
    Thomas Y. Michaelsen
    Marc Bennedbæk
    Lasse E. Christiansen
    Mia S. F. Jørgensen
    Camilla H. Møller
    Emil A. Sørensen
    Simon Knutsson
    Jakob Brandt
    Thomas B. N. Jensen
    Clarisse Chiche-Lapierre
    Emilio F. Collados
    Trine Sørensen
    Celine Petersen
    Vang Le-Quy
    Mantas Sereika
    Frederik T. Hansen
    Morten Rasmussen
    Jannik Fonager
    Søren M. Karst
    Rasmus L. Marvig
    Marc Stegger
    Raphael N. Sieber
    Robert Skov
    Rebecca Legarth
    Tyra G. Krause
    Anders Fomsgaard
    Mads Albertsen
    Genome Medicine, 14
  • [22] Emergence of the SARS-CoV-2 B.1.1.7 variant observed at the Poitiers University Hospital
    Hubert, Florent
    Chessa, Celine
    Beby-Defaux, Agnes
    Bourgoin, Anne
    Boinot, Laurence
    Noury, Ursula
    Lariviere, Andy
    Benlaassri, Mohammed
    Garcia, Magali
    Leveque, Nicolas
    JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (09) : 5254 - 5256
  • [23] Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera
    Supasa, Piyada
    Zhou, Daming
    Dejnirattisai, Wanwisa
    Liu, Chang
    Mentzer, Alexander J.
    Ginn, Helen M.
    Zhao, Yuguang
    Duyvesteyn, Helen M. E.
    Nutalai, Rungtiwa
    Tuekprakhon, Aekkachai
    Wang, Beibei
    Paesen, Guido C.
    Slon-Campos, Jose
    Lopez-Camacho, Cesar
    Hallis, Bassam
    Coombes, Naomi
    Bewley, Kevin R.
    Charlton, Sue
    Walter, Thomas S.
    Barnes, Eleanor
    Dunachie, Susanna J.
    Skelly, Donal
    Lumley, Sheila F.
    Baker, Natalie
    Shaik, Imam
    Humphries, Holly E.
    Godwin, Kerry
    Gent, Nick
    Sienkiewicz, Alex
    Dold, Christina
    Levin, Robert
    Dong, Tao
    Pollard, Andrew J.
    Knight, Julian C.
    Klenerman, Paul
    Crook, Derrick
    Lambe, Teresa
    Clutterbuck, Elizabeth
    Bibi, Sagida
    Flaxman, Amy
    Bittaye, Mustapha
    Belij-Rammerstorfer, Sandra
    Gilbert, Sarah
    Hall, David R.
    Williams, Mark A.
    Paterson, Neil G.
    James, William
    Carroll, Miles W.
    Fry, Elizabeth E.
    Mongkolsapaya, Juthathip
    CELL, 2021, 184 (08) : 2201 - +
  • [24] Introduction and transmission of SARS-CoV-2 lineage B.1.1.7, Alpha variant, in Denmark
    Michaelsen, Thomas Y.
    Bennedbaek, Marc
    Christiansen, Lasse E.
    Jorgensen, Mia S. F.
    Moller, Camilla H.
    Sorensen, Emil A.
    Knutsson, Simon
    Brandt, Jakob
    Jensen, Thomas B. N.
    Chiche-Lapierre, Clarisse
    Collados, Emilio F.
    Sorensen, Trine
    Petersen, Celine
    Le-Quy, Vang
    Sereika, Mantas
    Hansen, Frederik T.
    Rasmussen, Morten
    Fonager, Jannik
    Karst, Soren M.
    Marvig, Rasmus L.
    Stegger, Marc
    Sieber, Raphael N.
    Skov, Robert
    Legarth, Rebecca
    Krause, Tyra G.
    Fomsgaard, Anders
    Albertsen, Mads
    GENOME MEDICINE, 2022, 14 (01)
  • [25] Effect of the new SARS-CoV-2 variant B.1.1.7 on children and young people
    Brookman, Sarah
    Cook, James
    Zucherman, Mark
    Broughton, Simon
    Harman, Katharine
    Gupta, Atul
    LANCET CHILD & ADOLESCENT HEALTH, 2021, 5 (04): : E9 - E10
  • [26] SARS-CoV-2 B.1.1.7 Decline Is Not Driven by the Introduction of a More Successful Variant
    Rodriguez-Grande, Cristina
    Buenestado-Serrano, Sergio
    Alcala, Luis
    Sola-Campoy, Pedro J.
    Molero-Salinas, Andrea
    Otero-Sobrino, Alvaro
    Rodriguez-Grande, Jorge
    de la Cueva Garcia, Victor Manuel
    Adan-Jimenez, Javier
    Rico-Luna, Carla
    Losada, Carmen
    Catalan, Pilar
    Munoz, Patricia
    Perez-Lago, Laura
    de Viedma, Dario Garcia
    MICROBIOLOGY SPECTRUM, 2021, 9 (03):
  • [27] Idiopathic Intracranial Hypertension Associated with SARS-CoV-2 B.1.1.7 Variant of Concern
    Khalid, Muhammad Faran
    Micieli, Jonathan A.
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2022, 49 (03) : 472 - 473
  • [28] Multiorgan tropism of SARS-CoV-2 lineage B.1.1.7
    Ondruschka, Benjamin
    Heinrich, Fabian
    Lindenmeyer, Maja
    Edler, Carolin
    Moebius, Dustin
    Czogalla, Jan
    Heinemann, Axel
    Braun, Fabian
    Aepfelbacher, Martin
    Luetgehetmann, Marc
    Huber, Tobias B.
    INTERNATIONAL JOURNAL OF LEGAL MEDICINE, 2021, 135 (06) : 2347 - 2349
  • [29] Early introductions and transmission of SARS-CoV-2 variant B.1.1.7 in the United States
    Alpert, Tara
    Brito, Anderson F.
    Lasek-Nesselquist, Erica
    Rothman, Jessica
    Valesano, Andrew L.
    MacKay, Matthew J.
    Petrone, Mary E.
    Breban, Mallery, I
    Watkins, Anne E.
    Vogels, Chantal B. F.
    Kalinich, Chaney C.
    Dellicour, Simon
    Russell, Alexis
    Kelly, John P.
    Shudt, Matthew
    Plitnick, Jonathan
    Schneider, Erasmus
    Fitzsimmons, William J.
    Khullar, Gaurav
    Metti, Jessica
    Dudley, Joel T.
    Nash, Megan
    Beaubier, Nike
    Wang, Jianhui
    Liu, Chen
    Hui, Pei
    Muyombwe, Anthony
    Downing, Randy
    Razeq, Jafar
    Bart, Stephen M.
    Grills, Ardath
    Morrison, Stephanie M.
    Murphy, Steven
    Neal, Caleb
    Laszlo, Eva
    Rennert, Hanna
    Cushing, Melissa
    Westblade, Lars
    Velu, Priya
    Craney, Arryn
    Cong, Lin
    Peaper, David R.
    Landry, Marie L.
    Cook, Peter W.
    Fauver, Joseph R.
    Mason, Christopher E.
    Lauring, Adam S.
    St George, Kirsten
    MacCannell, Duncan R.
    Grubaugh, Nathan D.
    CELL, 2021, 184 (10) : 2595 - +
  • [30] The first familial cluster of the B.1.1.7 variant of SARS-CoV-2 in the northeast of Italy
    Lo Menzo, Sara
    Marinello, Serena
    Biasin, Matteo
    Terregino, Calogero
    Franchin, Elisa
    Crisanti, Andrea
    Cattelan, Annamaria
    INFECTION, 2021, 49 (06) : 1341 - 1345